英文名稱
5-Aminoimidazole-4-carboxamide-1-Beta-D-Ribofuranosyl 5’-Monophosphate
5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖基5′-單磷酸
純度
97.56%
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
DMSO (Slightly, Heated, Sonicated), Methanol (Slightly), Water (Slightly)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
5-Aminoimidazole-4-carboxamide-1-b-D-ribofuranosyl 5’-Monophosphate causes accumulation of monophosphorylated derivative 5-aminoimidaz ole-4-carboxamide ribonucleoside (ZMP) and consequent phosphorylation and activation of AMP-activated protein kinase (AMPK) in intact cells. It is important in treatment of metabolic diseases such as type 2 diabetes.